Search
Search Results
##search.searchResults.foundPlural##
-
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3709PDF: 2401HTML: 23682Untitled: 352Untitled: 311Untitled: 331 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1525PDF: 670HTML: 4208 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2177PDF: 2056HTML: 816 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1618PDF: 1437HTML: 126 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
4371PDF: 2116HTML: 294 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1125PDF: 602HTML: 354 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1489PDF: 594HTML: 314 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2567PDF: 1106HTML: 1684Fig 1: 289Tab I: 271Cover Letter: 287 -
Pseudo-differentiation syndrome
1582PDF: 755HTML: 10893Figure 1: peripheral blood showing myeloblasts with auer rods: 175Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 151Figure 3: CXR showing pulmonary infiltartes with consolidation: 181Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 161Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 156 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2377PDF: 1117HTML: 4132Cover Letter: 302Figure 1: 299Figure 2: 289Table 1: 277 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4761PDF: 1840HTML: 1435 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
912PDF: 979PDF Supp. Files: 121HTML: 274 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2280PDF: 867HTML: 3295 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1797PDF: 834HTML: 1526 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1556PDF: 911HTML: 8697Fig 3 Savini: 262Fig 2 Savini: 259Fig 1 Savini Chest TC: 244Author letter to referees: 255 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1340PDF: 679HTML: 2934ATRA induced Reactive Hemophagocytosis: A Case Report: 264 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
5056PDF: 1935HTML: 2908Untitled: 351 -
-
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1136PDF: 588HTML: 761 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
5040PDF: 1975HTML: 2229 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1495PDF: 1158HTML: 494 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4273PDF: 1261HTML: 2140Fig.1: 253Fig. 2: 151Table 1: 263Table2: 289Table 3: 282 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4280PDF: 1371HTML: 2136Table 1: 259 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1812PDF: 1181HTML: 530







